Covaxin may take at least 2 months to scale up2 min read 15 Apr 2021, 11:51 PM IST
Talks between Panacea Biotec and Bharat Biotech, which are at an early stage, started earlier this month following a nudge by the Department of Biotechnology
Expansion of Bharat Biotech International’s Covaxin capacity is likely to take at least two months as the repurposing of its Bengaluru facility, which earlier made animal vaccines, is underway even as talks with Panacea Biotec to contract-manufacture the vaccine have just started, three people familiar with the development said. “It takes about four to six months to repurpose a plant to produce the inactivated vaccine. It is unlikely that they will be scaling up their production next month also. For Panacea, it could take about two to three months at least after it signs a contract manufacturing deal with Bharat to start producing Covaxin," one of the three people said.
Select your Category